DESTINY-Endometrial01 is a global, multicenter, randomized, open-label phase 3 trial evaluating the efficacy and safety of ENHERTU (5.4 mg/kg) in combination with rilvegostomig or pembrolizumab ...

Review ECA Integrated Solution Bhd (0267:XKLS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

We want to avoid claims that limiters are causing more accidents, particularly in the early phase. 6. A bigger safety picture Speed limiters are powerful, but not the only answer.

Tune Protect Group Bhd advanced stock charts by Barron's. View 5230 historical stock data and compare to other stocks, and exchanges.

The Calibr-Skaggs Institute for Innovative Medicines, the drug development division of Scripps Research, today announced a milestone in cancer treatment with the dosing of the first patient in a ...

Russian President Vladimir Putin said on Thursday (Jun 19) said that he was ready to meet his Ukrainian counterpart Volodymyr Zelensky, but only in a “final phase” of negotiations. Despite ...

The best overall (AMD AM5) If you're after a feature-packed Mini-ITX motherboard with a solid upgrade path ahead of it, look no further than the Asus ROG Strix X870-I Gaming WiFi. It's an ...

This review elucidates state-of-the-art clinical studies on active specific immunotherapy with tumor vaccines. It refers solely to randomized studies and has a special focus on patient's survival ...

Nota AI’s DMS solution, optimized for RA8P1, achieves approximately 50 frames per second (FPS)—a notable benchmark for real-time monitoring. Powered by NetsPresso®, Nota AI’s proprietary AI model ...